Filing metadata

Accession number
0001104659-22-110940
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Oct 24, 2022
Reporting period
Oct 20, 2022
Description
Insider transaction

Explore SEC Filings Hub